Repurposing pertuzumab for adjuvant treatment of breast cancer patients with HER2-positive brain metastases (2015–2016)

Grant type:
ANZBCTG Discretionary Funding - Research Seed Funding
Researchers:
  • Head, Discipline of Pathology
    UQ Centre for Clinical Research
    Faculty of Medicine
  • Postdoctoral Research Scientist
    UQ Centre for Clinical Research
    Faculty of Medicine
Funded by:
ANZ Breast Cancer Trials Group Limited